<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Autohydrolysis of Diglycine‐Activated Succinic Esters Boosts Cellular Uptake</title></titleStmt>
			<publicationStmt>
				<publisher>Wiley-VCH</publisher>
				<date>09/04/2023</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10503798</idno>
					<idno type="doi">10.1002/anie.202308022</idno>
					<title level='j'>Angewandte Chemie International Edition</title>
<idno>1433-7851</idno>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">36</biblScope>					

					<author>Jiaqi Guo</author><author>Weiyi Tan</author><author>Hongjian He</author><author>Bing Xu</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[<title>Abstract</title> <p>Rapid cellular uptake of synthetic molecules remains a challenge, and the motif frequently employed to generate prodrugs, succinic ester, unfortunately lowers the efficacy of the desired drugs due to their slow ester hydrolysis and low cell entry. Here we show that succinic ester‐containing diglycine drastically boosts the cellular uptake of supramolecular assemblies or prodrugs. Specifically, autohydrolysis of the diglycine‐activated succinic esters turns the nanofibers of the conjugates of succinic ester and self‐assembling motif into nanoparticles for fast cellular uptake. The autohydrolysis of diglycine‐activated succinic esters and drug conjugates also restores the efficacy of the drugs. 2D nuclear magnetic resonance (NMR) suggests that a “U‐turn” of diglycine favors intramolecular hydrolysis of diglycine‐activated succinic esters to promote autohydrolysis. As an example of rapid autohydrolysis of diglycine‐activated succinic esters for instant cellular uptake, this work illustrates a nonenzymatic bond cleavage approach to develop effective therapeutics for intracellular targeting.</p>]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This communication reports that conjugating simple diglycine-activated succinic esters to self-assembling molecules or drugs results in autohydrolysis to enable instant cellular uptake of the supramolecular assemblies or drugs. Peptides are emerging as an important class of building blocks to generate supramolecular assemblies, <ref type="bibr">[1]</ref> and the conjugation of peptides to drugs has received increasing attention for designing molecules to deliver drugs into cells. <ref type="bibr">[1i,2]</ref> In a recent study that aimed at enzymatic hydrolysis of succinic ester prodrugs, we conjugated dipeptides to chloramphenicol succinate to generate enzymatically controlled assemblies. We found that conjugating diglycine to succinate lowers the cytotoxicity of chloramphenicol to bone marrow stromal cells while maintaining the activity of the conjugates against Gram-negative bacteria. <ref type="bibr">[3]</ref> In our investigation into the alternative amino acids to glycine, we discovered a significant decrease in the antibacterial activity of other chloramphenicol conjugates, particularly when glycine was not directly attached to the succinic acid. <ref type="bibr">[4]</ref> This finding challenges the assumption that esterases, which are typically nonselective, catalyze the hydrolysis of the ester bond in the conjugates.</p><p>The above question stimulates us to further investigate the uniqueness of incorporating glycine in succinic ester. We found that conjugating diglycine motif (GG) to hemisuccinate leads to the rapid autohydrolysis of the succinate ester under physiological pH, such as in phosphate-buffered saline (PBS). Removing GG or replacing GG with mono-glycine (G), dialanine (AA), or di-&#946;-alanine (BABA) motif abolishes the hydrolysis in PBS. When the compound bears selfassembly motifs, the hydrolysis results in a morphological transformation from nanofibers to nanoparticles, and thus enhancing cellular uptake of the peptide assemblies. The generality of autohydrolysis was supported by pyrenyl (Py) and biphenyl (BP) conjugated diglycine succinic ester. When replacing the self-assembling motifs with drugs, conjugating GG to succinate prodrugs recover the efficacy of the drugs (Figure <ref type="figure">1A</ref>). 2D NMR of the diglycine-activated succinic esters s indicates a "U-turn" of diglycine, suggesting that intramolecular base-catalyzed hydrolysis promotes the autohydrolysis of succinic ester and subsequently boosts cell uptake of the products. This work represents a unique example of rapid autohydrolysis of esters for instant cellular uptake. This work also illustrates the modulation of the rate of nonenzymatic bond breaking for intracellular targeting.</p><p>Figure <ref type="figure">1B</ref> illustrates the rationale for molecular design. A fluorescent probe, nitrobenzoxadiazole (NBD), was conjugated to a rigid-rod motif, BP, to generate NBD-BP as a self-assembling motif because it is easy to image NBD-BP assemblies in cells. <ref type="bibr">[5]</ref> Subsequent conjugation of a succinic acid to NBD-BP generates the molecule NBD-BP-suc ( ). To examine the impact of glycine on the rate of hydrolysis, we added one or two glycine to the C-terminus of , generating NBD-BP-G (2) or NBD-BP-GG (3), respectively. The hydrolysis of 3 (Figure <ref type="figure">1C</ref>) leads to NBD-BP-OH (4). To investigate the roles of GG in autohydrolysis, we replaced it with BABA, which bears an extra methylene group in the amino acids, or AA, which has an additional branched methyl side chain, to produce NBD-BP-BABA (5) or NBD-BP-AA (6), respectively. To investigate the generality of the diglycine-promoted autohydrolysis, we introduced other self-assembling motifs or drugs. Specifically, substituting NBD-BP with Py yields Py-suc (7) and Py-GG (8), while removing the NBD motif leads to BP-suc (9) and BP-GG ( 0). Moreover, we selected two representative anticancer drugs, paclitaxel (Taxol) and camptothecin (CPT), both of which are hydrophobic and contain hydroxy groups for making succinate prodrugs. Thus, we synthesized Taxol-suc ( ), Taxol-GG ( 2), CPT-suc ( 3) and CPT-GG ( 4) for evaluating the recovery of drug efficacy in the absence or presence of diglycine conjugation. According to the results of 2D NMR (see below), we substituted the carboxy-terminal glycine in 3 with sarcosine to generate NBD-BP-GSAR ( 5) that bears a tertiary amide. We also introduced O-methylation of the carboxylic acid of 3 to generate NBD-BP-GG-OMe ( <ref type="formula">6</ref>). 5 and 6 act as the controls to eliminate the intramolecular hydrogen bonding at two possible sites in 3. Combining liquid-phase and solidphase synthesis, we synthesized the aforementioned compounds and used liquid chromatography-mass spectrometry to confirm their identities (Scheme S1 and Figure <ref type="figure">S1-S17</ref>).</p><p>These peptide conjugates, prior to hydrolysis, comprise a hydrophobic capping motif and a hydrophilic carboxyterminus. The hydrophilic carboxy-terminus may form disordered peripheries <ref type="bibr">[6]</ref> to allow hydrolysis. Given that hydrolysis results in the conversion of the molecule's hydrophilic region from carboxylic acid to hydroxy groups, we hypothesized that this transformation would impact the molecule's self-assembly behavior. Therefore, we examined the morphology of SA motif-capped -4 using TEM. The results revealed that -3 form nanofibers, while 4 generates amorphous aggregates in PBS (Figure <ref type="figure">2A</ref>). Based on these  findings, we hypothesized that the hydrolysis of -3 to 4 would lead to morphological transformation from nanofibers to aggregates. This hypothesis is supported by the 96 hincubation TEM results of 3 in PBS (Figure <ref type="figure">S18</ref>). We then sought to investigate the rate of hydrolysis with glycine conjugation. Bearing one glycine, the hydrolysis of 2 is pH sensitive. While 2 hardly hydrolyzes in water (pH = 6.0), the hydrolysis initiates at pH 7.4 in PBS, and accelerates in Minimum Essential Medium (MEM) (pH = 7.6) and saturated sodium bicarbonate (NaHCO 3 ) (pH = 8.5), reaching 90 % hydrolysis after 48 h (Figure <ref type="figure">2B</ref> and Figure <ref type="figure">S19</ref>). With diglycine conjugation, the hydrolysis of 3 remains pH sensitive but occurs at much faster rates. While 3 remains intact in water, it hydrolyzes quickly in PBS, reaching 60 % conversion in 48 h (Figure <ref type="figure">2C</ref>). 3 hydrolyzes faster in MEM and NaHCO 3 , approaching complete hydrolysis in 8 and 2 h, respectively (Figure <ref type="figure">S20</ref>). Diluted samples of 3 hydrolyze faster than the concentrated ones, indicating that selfassembly slows down the hydrolysis (Figure <ref type="figure">S21</ref>). Moreover, 3 hardly hydrolyzes in acidic conditions after 7 days (Figure <ref type="figure">S22</ref>). Therefore, 3 likely undergoes base-catalyzed autohydrolysis in aqueous solutions.</p><p>Removing the glycine conjugation, however, abolishes the hydrolysis. , 7, 9, , and 3 do not hydrolyze in PBS (Figure <ref type="figure">2D</ref>). Further investigation into the hydrolysis of in MEM and NaHCO 3 shows no conversion after 48 h (Figure <ref type="figure">S23</ref>). We then determined the hydrolysis of other analogs. Elongation of the molecule (5) renders more flexibility, while introducing amino acid side chains ( <ref type="formula">6</ref>) makes the molecule more rigid. Both 5 and 6 remain unhydrolyzed in PBS (Figure <ref type="figure">2E</ref> and Figure <ref type="figure">S24</ref>), indicating that the hydrolysis relies on the unique conformation of diglycine. However, the hydrolysis is less sensitive to the hydrophobic part of the molecule, where Py (8), BP ( 0), Taxol ( 2), and CPT ( 4) capped diglycine conjugates all readily hydrolyze in PBS (Figure <ref type="figure">2E</ref> and Figure <ref type="figure">S24</ref>).</p><p>Based on the increasing speed of hydrolysis of -3 at cell-free conditions, we sought to evaluate their cellular uptake. Confocal images show that hardly enters cells, while 2 and 3 are readily taken up by the cells, with more intense intracellular fluorescence for 3 (Figure <ref type="figure">3A</ref>). 4 also quickly enters cells with similar cellular distribution to that of 2 and 3 (Figure <ref type="figure">S25</ref>). Based on these observations, we hypothesized that the autohydrolysis happens extracellularly to initiate the morphological transformation of 2-3 from nanofibers to aggregates. Furthermore, the charge removal of the molecule after hydrolysis facilitates its entry into the cells. Additionally, the cellular uptake of 2-3 is nonselective across the tested cells, agreeing with the autohydrolysis in physiological buffers under cell-free conditions. Quantification of the cellular uptake over 20 minutes reveals similar results, where 3 instantly enters cells and the difference between analogs is more significant than that between cell lines (Figure <ref type="figure">3B</ref>). While 5 and 6 also enter cells, their rates of entry are lower than that of 3, corresponding to their reduced autohydrolysis (Figure <ref type="figure">3C</ref>).</p><p>Considering that succinic esterification is a common prodrug strategy to enhance the water solubility of hydrophobic drugs, we replaced the self-assembling motifs with anticancer drugs and evaluated the efficacy of the diglycine prodrugs. Due to the inertness of the ester bonds in the conjugate of succinate and drugs, the resulting prodrugs often suffer from incomplete bioconversion at the therapeutic targets and undergo rapid excretion from bodies before exerting intended therapeutic effects, therefore loss of efficacy. Therefore, we hypothesized that the hydrolysis of diglycine conjugates, which is independent to esterase and hydrolyzes sufficiently fast, would recover drug efficacy. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assays and half-maximal inhibitory concentration (IC 50 ) determination of Taxol and CPT derivatives support this hypothesis. The efficacies of succinate prodrugs and 3 are compromised, while diglycine conjugation to generate prodrug 2 and 4 recovers the efficacy in both HeLa and Saos-2 cell lines (Figure <ref type="figure">3D</ref>-E and Figure <ref type="figure">S26</ref>). Using succinate diglycine conjugation, the recovery of Taxol and CPT provides insights into prodrug strategy to retain efficacy at the same time increase water solubility.</p><p>After characterizing the analogs mentioned above, we aimed to investigate the hydrolysis mechanism. For this purpose, we used 1 H-1 H Nuclear Overhauser Effect Spectroscopy (NOESY) to compare the spatial proximity within the molecules of compounds 3, 5, and 6. Following the peak assignments based on their 1 H-NMR spectra (Figure <ref type="figure">S27</ref>), we utilized Correlation Spectroscopy (COSY) to investigate the through-bond correlations (Figure <ref type="figure">S28</ref>), and NOESY to determine the through-space correlations. The NOESY signals were assigned by excluding the COSY signals (Figure 4A and Figure S29-S34). Based on the chemical structures, the observed NOE signals suggest a possible conformation of 3, 5, and 6 (Figure <ref type="figure">4B</ref>): The carboxy-terminus in compound 3 bends over (or a "U-turn"), enabling proximity between H p and H l , thereby implying the possibility of intramolecular base-catalyzed ester hydrolysis. However, no NOE signal was observed near the ester bond in 5 and 6, indicating that these molecules adopt different conformations that disfavor intramolecular hydrolysis, which corresponds to their inability to undergo hydrolysis in PBS (Figure <ref type="figure">2E</ref>) and reduced cellular uptake (Figure <ref type="figure">3C</ref>).</p><p>Based on the molecular bending observed in 3, we investigated the importance of two carboxy-terminal nucleophiles: the secondary amide and carboxylic acid derived from the terminal glycine. To evaluate their contribution to hydrolysis, we synthesized compounds 5 and 6 by methylating the amide and methyl esterifying the carboxylic acid, respectively. The results show that 5 hardly hydrolyzes in PBS, similar to 2, while 6 readily hydrolyzes in PBS, achieving nearly 90 % conversion after 48 h, similar to 3 (Figure <ref type="figure">4C</ref>). Both compounds are able to undergo hydrolysis in NaHCO 3 (Figure <ref type="figure">S35</ref>). The hydrolysis tendency correlates with cellular uptake, where 6 enters cells more quickly than 5 (Figure <ref type="figure">4D</ref> and Figure <ref type="figure">S36</ref>). These results suggest the significance of the amide group in the carboxy-terminal diglycine motif in facilitating ester hydrolysis and provide a strategy to modulate the rate of autohydrolysis.</p><p>In conclusion, we have demonstrated that the conjugation of diglycine to a succinate enhances the hydrolysis of ester at physiological pH (in PBS). By employing this strategy to conjugate succinic diglycine with a self-assembling motif, cellular uptake can be significantly boosted. Additionally, conjugation with hydrophobic drugs restores their efficacy, highlighting the generality of this approach. Besides, this prodrug design strategy may also be applied to the pharmacophores with cell selectivity (e.g. 4-Hydroxytamoxifen), thereby minimizing off-target cytotoxicity. The hydrolysis of the analogs underscores the importance of the carboxy-terminal amide of the diglycine motif in promoting hydrolysis. This work emphasizes that modulating rate of nonenzymatic reactions through molecular design is an alternative means, in comparison to enzymatic reactions <ref type="bibr">[7]</ref> or pH response <ref type="bibr">[8]</ref> , to boost cellular uptake. Overall, this enzyme-independent, mild base-catalyzed ester hydrolysis approach reveals the broad potential of short peptides in prodrug design <ref type="bibr">[2a,9]</ref> , drug delivery, <ref type="bibr">[1i,2b,10]</ref> and intracellular targeting <ref type="bibr">[2c,d, 11]</ref> .</p></div><note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>Angew.Chem. Int. Ed. 2023, 62, e202308022 (3 of  5) &#169; 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH 15213773, 2023, 36, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/anie.202308022 by Brandeis University, Wiley Online Library on [24/10/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</p></note>
		</body>
		</text>
</TEI>
